Michal Graff Mitzmacher
Directeur Technique/Scientifique/R&D chez Elastagen Pty Ltd.
Profil
Michal Graff Mitzmacher is currently the Chief Technology Officer at Elastagen Pty Ltd.
She has a graduate degree from Tel-Aviv University and an undergraduate degree from Technion-Israel Institute of Technology.
Postes actifs de Michal Graff Mitzmacher
Sociétés | Poste | Début |
---|---|---|
Elastagen Pty Ltd.
Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | Directeur Technique/Scientifique/R&D | - |
Formation de Michal Graff Mitzmacher
Tel-Aviv University | Graduate Degree |
Technion-Israel Institute of Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Elastagen Pty Ltd.
Elastagen Pty Ltd. Medical SpecialtiesHealth Technology Elastagen Pty Ltd. produces and develops synthetic human elastin for medical device applications. Its products include skin rejuvenation, scar remodeling, skin tissue repair, wound healing, surgical glues and sealants. The firm developed a Elastatherapy treatments which offer the chance to restore the levels of Elastin in human skin, with benefits anticipated in both medical dermatology and cosmetic applications. The company was founded by Anthony Weiss in 2003 and is headquartered in Sydney, Australia. | Health Technology |